|
CPD will be awarded:
MMA CPD for conference: 16CPD points | MAVMA CPD for conference: 2CPD points
MSPTM 2022 Programme
Important note: The programme is scheduled based on Malaysia time (GMT +8hrs).
Programme as of 19 March 2022. It is subject to change without prior notice.
Important note: The programme is scheduled based on Malaysia time (GMT +8hrs).
Programme as of 19 March 2022. It is subject to change without prior notice.
MSPTM 2022 Speakers
Prof Hair
MSPTM 2022 Sponsors
Platinum Sponsor:
Accuflex Sdn Bhd
QIAGEN
IMASPRO
Valent Biosciences LLC
IMASPRO RESOURCES SDN BHD (IRSB) is principally engaged in the manufacturing and distribution of agrochemicals and environmental science products, both locally and internationally. We provide a comprehensive range of quality and cost-effective agrochemicals and environmental science products to cater for both the crop and non-crop protection requirements of our customers. Our research is carried out at our own 52-acre Research and Development (R&D) Center which is equipped with facilities for bio-efficacy trials, to facilitate profiling of new pesticides and evaluating new pesticides formulation for optimal bio-efficacy.
We stay at the forefront of the industry by undertaking continuous research and development so that our products meet the evolving industry requirements and expectations of our customers. Through our joint R&D efforts with the Malaysian Palm Oil Board, the Group successfully developed and launched the world’s first bio-palm based insecticide in 2007. Working with Institute for Medical Research, our group had successfully invented an innovative product that can easily and effectively eliminate the larvae of mosquitoes.
Contact Information
For more information on how our range of pest control products and services can meet your crop and non-crop protection challenges, please contact:
IMASPRO RESOURCES SDN BHD
37 JALAN BATAI LAUT 5 KAWASAN 16
TAMAN INTAN 41300 KLANG
SELANGOR, MALAYSIA
Tel: 603-3343 1633 Fax: 603-3343 1868
Email: imaspro@imaspro.com
or log in www.imaspro.com for more details.
QIAGEN Biotechnology Malaysia Sdn. Bhd.
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). Further information can be found at http://www.qiagen.com.
ACCUFLEX SDN BHD
Accuflex Sdn Bhd was established with the aim to provide a one-stop solution for customers in the field of life science research. We work with world class manufacturers to offer a wide range of solution for life science research, including molecular research, medical biotechnology, molecular diagnostics, bioengineering and nanotechnology. We are committed to providing the best resources and solutions for scientists across the region to effortlessly accelerate their research. As we strive towards the future, we are continuously expanding not only our workforce, product portfolio but also the range of services that we offer to be the best one-stop solution in life science you will ever need
ACCUFLEX SDN BHD
Mobile: +6017-905 1870 / +6012-212 9598 / +6012-3521252 / +6017-4849598
Email: joshua@accuflexcompany.com /mingteng@accuflexcompany.com
Website: https://accuflexcompany.com
Lab-Ind Resource Sdn Bhd & GeneSEQ Sdn Bhd
Lab-Ind Resource Sdn Bhd (LIR), established in 1999, is a biotech company that specializes in providing bespoke molecular solutions for the food and animal-health industry.
In 2007, the company set up a molecular laboratory focusing on aquatic disease detection and food safety for industrial players, universities, and government bodies, both in Malaysia and abroad. Our laboratory is MS ISO/IEC 17025: 2017 accredited and is authorised by the Department of Fishery as an Authorised testing provider for shrimp exports. Our laboratory processes more than 1,000 samples per month.
The laboratory has also expanded to provide contract testing services, Research & Development services, and consultancy for laboratory set-ups and capacity-and-capability building regionally.
Being a market leader in the industry, LIR recognized the potential of an advance technology platform: Next Generation Sequencing (NGS). In 2019, GeneSEQ Sdn Bhd was officially set up to provide NGS services to academia and industry. GeneSEQ Sdn Bhd provides a complete service, which covers sample handling through to bioinformatics analyses.
To date, GeneSEQ has completed projects and collaborations in fish feed composition analyses, SARS-CoV-2 genome sequencing, phylogeny study, and whole genome sequencing of aquatic diseases among many others. Our collaborators include NaFISH, Worldfish, industry partners (like GK Aqua Sdn Bhd), and researchers in universities across Malaysia (and the APAC region).
We welcome visitors and collaborators to visits our laboratories. Follow the link below for updates and more information:
Linkedin
: https://www.linkedin.com/company/lab-ind-resource-sdn-bhd
: https://www.linkedin.com/company/geneseq-sdn-bhd
General: www.mylabind.com
Geneseq : www.geneseq.co
Testing : www.mylabind.wixsite.com/labtesting2u
Facebook
: www.facebook.com/labtesting2u
: www.facebook.com/geneseqsdnbhd
: www.facebook.com/DLS.MY
As a global leader in public health vector control, Valent BioSciences has been working for decades to develop the most comprehensive range of target-specific biorational solutions for public health professionals who protect people around the world against vector-borne disease and nuisance insects.
Mosquitoes are one of the deadliest animals in the world today and mosquito-borne diseases are responsible for more than one million deaths per year. Sustained mosquito control efforts are critical to prevent outbreaks from these diseases, and Valent BioSciences’ Public Health team works tirelessly with public health professionals across the globe to address the threat of mosquito-borne disease and to protect human potential around the world.
Valent BioSciences’ proprietary formulations containing Bacillus thuringiensis subsp. Israelensis (Bti, strain AM65-52) in products such as VectoBac® provide sustainable, biological control of mosquito larvae that helps manage mosquitoes before they become biting, disease-vectoring adults.
The VectoBac WG formulation was the first bacterial larvicide to complete the World Health Organization Pesticide Evaluation Scheme (WHOPES). Various application methods of VectoBac WG allow for an effective supplement to Integrated Vector Management (IVM) programs aimed at reducing these species that have the capacity to transmit dengue, chikungunya, and yellow fever, as well as other arboviruses.
MSPTM 2022 e-Posters
Thank you to all the ePoster presenters for contributing beautiful posters for the conference.
The ePosters will be published on the MSPTM 2022 Conference Website from 15 - 31 March 2022.
*click the image to view ePoster
EP01: Prevalence of fear and disgust toward insect and non-insect arthropods among university students in Malaysia
Aishah Hani Binti Azil, Universiti Kebangsaan Malaysia
EP02: A survey on consumer concern about parasitic infection in meat
Fazly Ann Binti Zainalabidin, Veterinary Research Insitute, Malaysia
EP03: Genetic diversity of Aedes albopictus (Skuse) in Sarawak, Malaysia and other regions of the world
Lau Koon Weng, Universiti Malaya, Malaysia
EP04: Molecular characterization of Blastocystis spp. in farm animals
Lee Ii Li, Universiti Islam Antarabangsa Sultan Abdul Halim Mu'adzam Shah (UniSHAMS), Malaysia
EP05: A wild brown rat (Rattus norvegicus) infected with Trypanosoma lewisi and Leishmania tropica in Utmah district, Dhamar governorate, Yemen
Manal Ali Alashwal, Universiti Malaya, Malaysia
EP06: Histochemical and biochemical alterations of some tegumental enzymes of the model cestode Raillietina spp. treated with crude ethanolic extract of Schumannianthus dichotomus (Roxb.) Gagnep.
Manjil Gupta, Dinhata College, India
EP07: In silico characterization of a conserved hypothetical proteins from Plasmodium knowlesi as a vaccine candidate against malaria
Mohd Adilin Bin Yaacob, Institute for Medical Research (IMR), National Institutes of Health (NIH), Malaysia
EP08: Detecting SARS-CoV-2: A comparison of performance between rRT-PCR, rapid RT-PCR, LAMP and rapid antigen test
Nada Syazana Binti Zulkufli, BP Healthcare, Malaysia
EP09: RNA aptamer against recombinant human ICAM-1: Potential biomolecules for cerebral malaria adjunct therapy
Nik Abdul Aziz Bin Nik Kamarudin, Institute for Medical Research (IMR), National Institutes of Health (NIH), Malaysia
EP10: The differential characteristics of the expression vector affect the production of recombinant outer membrane protein A of Orientia tsutsugamushi
Noor Hanisa Harun, Universiti Teknologi MARA, Malaysia
EP11: The detection of anisakid larvae in Malaysia waters
Noorul Azliana Binti Jamaludin, Department of Fisheries Malaysia
EP12: A case of Laboulbeniales infestation on flies in Malaysia
Nur Aliah Natasha Binti Azmi, Universiti Teknologi MARA, Malaysia
EP13: Trypanosomiasis in a tiger - a case study
Premaalatha D/O Bathmanaban, Veterinary Research Insitute, Malaysia
EP14: Enterocytozoon hepatopenaeai (EHP) of white shrimp cultured in high density
Rohaiza Asmini binti Yahya, Department of Fisheries Malaysia
EP15: Optimization of nested PCR for detection of 56kDa type specific antigen gene of Orientia tsutsugamshi
Sa'adiah Binti Abdul Malek, Universiti Teknologi MARA, Malaysia
EP16: Modelling the initial stages of the COVID-19 outbreak in Malaysia using time series model
Sarbhan Singh A/L Lakha Singh, Ministry of Health Malaysia
EP17: Preliminary survey of gastrointestinal parasites in herbivorous livestock of Dooars regions of North Bengal in India
Subrata Saha, Cooch Behar Panchanan Barma University, India
EP18: Effects of satellite-based earth observation meteorological data on dengue cases in Malaysia
Tan Cia Vei, Institute for Medical Research (IMR), National Institutes of Health (NIH), Malaysia
EP19: Species composition and non-specific esterase activity of mosquitoes collected by using light trap at Kampung Dusun Nanding, Hulu Langat, Selangor, Malaysia
Yu Ke Xin, Management and Science University, Malaysia
Abstract submitters may choose their preferred method of presentation upon abstract submission. However, the final decision lies with the Scientific Committee. All abstracts will be reviewed and assigned to an appropriate session. Authors of the accepted abstracts will be notified of the mode of presentations as follow:
| Oral Presentation |
|
| Rapid Oral Presentation |
|
| Rapid Oral Presentation – Student Competition |
|
| Electronic Poster (e-Poster) |
|
| 1. Malaria | 8. Vector Biology & Control |
| 2. Dengue | 9. Neglected Tropical Diseases |
| 3. Covid-19 | 10. Medical & Forensic Entomology |
| 4. Emerging Zoonoses | 11. Medical Microbiology & Parasitology |
| 5. Antibiotic Resistance | 12. Aquatic, Exotic & Wildlife Diseases |
| 6. Insecticide Resistance | 13. General Topics |
| 7. Veterinary Parasitology |
Guidelines and Terms & Conditions for Abstract Submissions
- Submissions should be sent electronically via the conference website ONLY.
- Submissions should be written in English with a maximum of 250 words.
- Each presenter may submit one abstract.
- Abstract must be submitted in both Microsoft Word (.doc/ .docx) and PDF (.pdf) formats.
- Submissions should be thoroughly checked for spelling and grammar before submission as they will be reproduced as submitted by author.
- Changes will not be entertained once the abstract has been submitted.
- Submitters are advised to seek assistance to proof read the abstract if English is not their first language.
- It is the sole responsibility of the authors to ensure accuracy of scientific content and language.
- The abstract should not contain graphics or references.
- Please use abbreviations with restraint.
Consent, Permission & Copyright:
Submitters must conform to the following:
- To accept responsibility for the accuracy of the submitted abstract and understand that amendment is not allowed once it is submitted and information provided will be published exactly as submitted.
- All co-authors are aware of and give consent to the content of the abstract and data presented before it is submitted. The submitter accepts responsibility as the contact person for all correspondence about the abstract and to share information with all authors about its status.
- Submission of abstracts implies the author’s agreement to publish the abstract in all Conference publications including the website, i.e. submitters are responsible to secure any copyright/permissions clearance required relating to any previous presentations, equipment or other material for inclusion in the MSPTM 2022 Annual Scientific Conference publications.
- Submitters are responsible to obtain permission from any relevant regulatory authority and obtain consent where appropriate.
- Submitters are responsible to ensure the work is original and that it does not infringe upon any copyright, proprietary or personal right of party.
- Submitters are responsible to identify and sort out any potential conflicts of interest e.g. financial interest in products or processes described in the presentation materials, stock ownership, and membership on an advisory board or board of directors or other substantive relationships.
- Submission of the online Registration and Abstract Submission form indicates the submitter has agreed to all the terms & conditions with regards to the conference registrations and abstract submissions as listed on the conference website (http://114.7f7.myftpupload.com/msptm-2022/).
Condition of Acceptance
It is a pre-requisite of the acceptance of the abstract that the submitter must register to attend the virtual Conference. Abstracts submitted before payment of registration are eligible for an offer of acceptance. However, final acceptance requires registration with full payment by 5 March 2022.
Abstract Title:
Calibri, font size 12, bold, centre alignment, sentence case.
Authors & Co-authors:
Calibri, font size 11, centre alignment
Underline the name of the first author.
Superscript with number to indicate affiliations of each author.
Superscript with “*” to indicate corresponding author.
Affiliations:
Calibri, font size 10, Italic, align left
Superscript with number to indicate affiliations of each author.
Abstract Content:
Calibri, font size 11, justify alignment, not more than 250 words.
The abstract content should be informative and stand alone in its content and meaning. It should include a brief introduction, methods used, key results, brief discussion and a conclusion.
MSPTM 2022 Registration
| REGISTRATION TYPE | REGISTRATION FEE |
|---|---|
| MSPTM MEMBER | MYR 100.00 |
| NON-MSPTM MEMBER | MYR 180.00 |
| STUDENT | MYR 50.00 |
| ASEAN ASSOCIATION OF PARASITOLOGY | MYR 100.00 |
| SENIOR CITIZEN (age >60) | Complimentary |
- Participants may register via online registration at msptm.org.
- Online registration is open until 10 March 2022 by 5pm (GMT +8hrs).
- The conference accepts full payment of registration fee via online bank transfer or online credit card payment. Payment via ePerolehan is only applicable to Malaysian government agencies. Full payment must be received latest by 10 March 2022 by 5pm (GMT +8hrs).
- Confirmation letter of registration will be sent via email upon full payment of the registration fee received.
- Registrations fee paid are non-transferrable and non-refundable. Non-attendance, otherwise referred as a “no show” does not signify cancellation and will not receive any refund.
- The Organiser reserves the rights, and will inform Participants on any alteration to any of the arrangements for the Conference including the cancellation of the event should unforeseen circumstances require such action. In the special circumstances that the entire event has to be cancelled, the Organiser will refund the registration fee to the Participant. Any charges imposed by banks and Credit Card issuers will be borne by the Registrants. The Organiser will not be liable for any other associated costs and any inconveniences incurred to the Participants due to the cancellation.
- The meeting will be audio and video recorded and/or live broadcasted through web streaming. When attending this meeting you agree on the collection and on the processing of your personal data and on the publication of the audio and video recordings and/or web streaming. Depending on the type of meeting, publication of the recordings might be on a publicly available website or on an access restricted site.
- The Organiser reserves the right to make changes were deemed necessary, with or without prior notice to parties concerned. All disputes are subjected to the Malaysian Law.
- Submission of the registration and abstract submission form indicates the submitter has agreed to all the terms & conditions with regards to the conference registrations and abstract submissions as listed on the conference website (https://msptm.org/msptm-2022-conference/).
Platinum Sponsor
Gold Sponsor
Silver Sponsor
